JP2025501169A5 - - Google Patents
Info
- Publication number
- JP2025501169A5 JP2025501169A5 JP2024539090A JP2024539090A JP2025501169A5 JP 2025501169 A5 JP2025501169 A5 JP 2025501169A5 JP 2024539090 A JP2024539090 A JP 2024539090A JP 2024539090 A JP2024539090 A JP 2024539090A JP 2025501169 A5 JP2025501169 A5 JP 2025501169A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- formulation according
- parenteral formulation
- bond
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163293985P | 2021-12-27 | 2021-12-27 | |
| US63/293,985 | 2021-12-27 | ||
| US202263313472P | 2022-02-24 | 2022-02-24 | |
| US63/313,472 | 2022-02-24 | ||
| PCT/US2022/053935 WO2023129502A1 (en) | 2021-12-27 | 2022-12-23 | Respiratory stimulant parenteral formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501169A JP2025501169A (ja) | 2025-01-17 |
| JP2025501169A5 true JP2025501169A5 (enExample) | 2026-01-05 |
Family
ID=86992921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024539090A Pending JP2025501169A (ja) | 2021-12-27 | 2022-12-23 | 呼吸刺激薬非経口製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230210857A1 (enExample) |
| EP (1) | EP4456900A4 (enExample) |
| JP (1) | JP2025501169A (enExample) |
| KR (1) | KR20240150426A (enExample) |
| AU (1) | AU2022426492A1 (enExample) |
| CA (1) | CA3242509A1 (enExample) |
| MX (1) | MX2024008162A (enExample) |
| TW (1) | TW202333732A (enExample) |
| WO (1) | WO2023129502A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4543455A4 (en) * | 2022-06-24 | 2026-06-03 | Enalare Therapeutics Inc | METHODS OF TREATMENT FOR NEUROLOGICAL VENTILATORY FAILURE |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69729880T3 (de) * | 1996-12-24 | 2012-05-10 | Biogen Idec Ma Inc. | Stabile flüssige interferon-zubereitungen |
| SG10201601507YA (en) * | 2010-11-29 | 2016-04-28 | Galleon Pharmaceuticals Inc | Novel compounds as respiratory stimulants for treatment of breathing control disorders or diseases |
| US20120295911A1 (en) * | 2010-11-29 | 2012-11-22 | Galleon Pharmaceuticals, Inc. | Novel Compounds and Compositions for Treatment of Breathing Control Disorders or Diseases |
| AU2012250050B2 (en) * | 2011-04-28 | 2017-04-06 | Platform Brightworks Two, Ltd. | Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same |
| BR112015011213A2 (pt) * | 2012-11-15 | 2017-08-29 | Galleon Pharmaceuticals Inc | Composto, composição farmacêutica, método de prevenção ou tratamento de um distúrbio ou doença de controle respiratório em um indivíduo, método de prevenção de desestabilização ou de estabilização do ritmo respiratório em um indivíduo, método de preparação de o,n-dimetil-n-[4-(n-propilamina)-6-(prop-2-inilamina)-[1,3,5]triazin-2-il]-hidroxilamina, e composição. |
| GB201502412D0 (en) * | 2015-02-13 | 2015-04-01 | Canbex Therapeutics Ltd | Therapeutic use |
-
2022
- 2022-12-23 JP JP2024539090A patent/JP2025501169A/ja active Pending
- 2022-12-23 WO PCT/US2022/053935 patent/WO2023129502A1/en not_active Ceased
- 2022-12-23 AU AU2022426492A patent/AU2022426492A1/en active Pending
- 2022-12-23 EP EP22917259.8A patent/EP4456900A4/en active Pending
- 2022-12-23 MX MX2024008162A patent/MX2024008162A/es unknown
- 2022-12-23 KR KR1020247025381A patent/KR20240150426A/ko active Pending
- 2022-12-23 US US18/088,137 patent/US20230210857A1/en active Pending
- 2022-12-23 CA CA3242509A patent/CA3242509A1/en active Pending
- 2022-12-27 TW TW111150221A patent/TW202333732A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024001048A5 (enExample) | ||
| JP2025511227A5 (enExample) | ||
| US12383528B2 (en) | Cromolyn esters and uses thereof | |
| JP2021501754A5 (enExample) | ||
| JP2022000482A5 (enExample) | ||
| RU2008133654A (ru) | Способ и лекарственное средство для лечения тяжелой сердечной недостаточности | |
| RU2000131183A (ru) | Производные оксииминоалкановой кислоты | |
| RU2009144538A (ru) | Новые циклические пептидные соединения | |
| JP2024510939A5 (enExample) | ||
| JP2012001555A (ja) | チアゾール誘導体を含む水性組成物 | |
| AU2010324249B2 (en) | Azilsartan organic amine salts, preparation method and use thereof | |
| WO2022146914A1 (en) | Cromolyn derivatives and uses thereof | |
| JP2024545787A5 (enExample) | ||
| SK4742001A3 (en) | Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection | |
| JPH06505265A (ja) | ヒスタミンｈ↓３受容体に対する作動的または拮抗的活性を有するイミダゾール誘導体 | |
| JP2025508359A5 (enExample) | ||
| JPH10316662A5 (enExample) | ||
| RU2006108572A (ru) | Соединения для лечения метаболических нарушений | |
| JP2026503618A5 (enExample) | ||
| KR940702491A (ko) | 옥사졸리돈 유도체 | |
| JP2024540198A5 (enExample) | ||
| JP2023109829A5 (enExample) | ||
| JP2012504584A5 (enExample) | ||
| JPS5840552B2 (ja) | １，４− ベンゾジオキサンノ アミンユウドウタイノセイホウ | |
| RU2003130062A (ru) | Бициклические производные гуанидина и их терапевтическое использование |